We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Dan Theodorescu MD, PhD

Dan Theodorescu MD, PhD

Director of the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angeles, CA

Dan Theodorescu MD PhD is now Director of the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center in  Los Angeles, CA.  Previously, he was Director of the University of Colorado Comprehensive Cancer Center and Professor of Urology and Pharmacology. Theodorescu has focused his scientific career on translational bladder cancer biology. His application of computational biology led to the discovery of genes that drive this and other cancers, while providing novel biomarkers and therapeutic targets that serve as the foundation for personalized therapeutic approaches currently tested in clinical trials. He also led the discovery and development of new therapeutics in several human cancer types. His experience as a practicing surgeon provides him with insights that help direct his research to make the most impact on human health.

Recent Contributions to PracticeUpdate:

  1. Comparison of White Light, Photodynamic Diagnosis, and Narrow-Band Imaging in Detection of Carcinoma In Situ or Flat Dysplasia at Transurethral Resection of the Bladder
  2. Should Patients Newly Diagnosed With Bladder Cancer Be Screened for Lung Cancer?
  3. Radical Cystectomy for Bladder Cancer in Patients With and Without a History of Pelvic Irradiation
  4. Predictive Mutations in High-Grade Bladder Cancer

Recently Updated